NASDAQ: CGNT
$ 1.98 0.00 (0.00%)
Day High: N/A
Day Low:  N/A
Volume:    N/A
4:00 PM ET on Feb 17, 2017
Delayed ~20 min., by eSignal.
 
 
Press Releases
 
Press Releases
  Date Title View
Mar 30, 2015
MINNEAPOLIS and ORANGEBURG, N.Y., March 30, 2015 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ: UPI) and Vision-Sciences, Inc. (NASDAQ: VSCI) shareholders have voted at the special meeting of each company's shareholders held today to approve the previously announced agreement and plan of merger between the two companies. "We are pleased with the outco...
Feb 4, 2015
ORANGEBURG, NY -- (Marketwired) -- 02/04/15 -- Vision-Sciences, Inc. (NASDAQ: VSCI), a leading provider of unique flexible endoscopic products, today announced financial results for the three- and nine-month periods ended December 31, 2014. Third Quarter Fiscal 2015 Highlights Net sales increased 9% t...
Jan 22, 2015
ORANGEBURG, NY / ACCESSWIRE / January 22, 2015 / Vision-Sciences, Inc. (Nasdaq: VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable EndoSheath(R) technology, today announced that the Company will release its financial results for the third quarter fiscal 2015, ended December 31, 2014, after ...
Dec 29, 2014
ORANGEBURG, N.Y., Dec. 29, 2014 (GLOBE NEWSWIRE) -- A new peer-reviewed research study published in the American Journal of Gastroenterology concludes sedation-free transnasal esophagoscopy (TNE) may provide an effective alternative strategy to conventional sedated esophagogastroduodenoscopy (EGD) for esophageal assessment and Barrett's Esophagus (...
Dec 22, 2014
All-Stock Combination Creates New Company with Expanded Product Offerings in UrologyConference Call Today at 11:00 AM EST MINNEAPOLIS and ORANGEBURG, N.Y., Dec. 22, 2014 (GLOBE NEWSWIRE) -- Uroplasty, Inc. (Nasdaq:UPI) and Vision-Sciences, Inc. (Nasdaq:VSCI) entered into a definitive merger agreement under which the two companies will combine i...
Nov 25, 2014
ORANGEBURG, N.Y., Nov. 25, 2014 (GLOBE NEWSWIRE) -- The 16th Annual GERD Awareness Week, November 23rd-29th is dedicated to heightening awareness of Gastroesophageal Reflux Disease, or GERD, and encouraging people experiencing GERD-related symptoms to consult their physicians. The week emphasizes educating people on common and uncommon symptoms of ...
Nov 5, 2014
ORANGEBURG, N.Y., Nov. 5, 2014 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq: VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable EndoSheath® technology, today announced financial results for the second quarter and first six months of fiscal (FY) 2015, ended September 30, 2014. High...
Nov 4, 2014
ORANGEBURG, N.Y., Nov. 4, 2014 (GLOBE NEWSWIRE) -- A new study published in the Journal of the American Medical Association ("JAMA") (Volume 312, issue No. 14) focused on an endoscopic outbreak that included bacteria transmission of New Delhi metallo-β-lactamase (NDM)-producing Escherichia coli, via endoscope to nine patients at a hospital in ...
Oct 27, 2014
A Simple Procedure and Novel Technology Provide an Alternative to Sedated Esophageal Exams ORANGEBURG, N.Y., Oct. 27, 2014 (GLOBE NEWSWIRE) -- The report by the New York City Office of the Chief Medical Examiner on the death of Joan Rivers points to a "predictable complication of medical therapy." Vision-Sciences (Nasdaq:VSCI) believes one solu...
Oct 1, 2014
ORANGEBURG, N.Y., Oct. 1, 2014 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable EndoSheath® technology, today announced the CE Mark approval and European launch of the company's next generation video bronchoscope and EndoSheath® ...
1
...
NextLast
= add release to Briefcase

View archived press releases from Vision-Sciences and Uroplasty